medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2006, Number 3

<< Back Next >>

Ann Hepatol 2006; 5 (3)

Early experience of Budd-Chiari syndrome treatment with transjugular intrahepatic portosystemic shunt

López-Méndez E, Chávez-Tapia NC, Avila-Escobedo L, Cabrera-Aleksandrova T, Uribe M

Language: English
References: 17
Page: 157-160
PDF size: 130.70 Kb.


Text Extraction

The Budd–Chiari syndrome is a heterogeneous group of disorders characterized by obstruction of hepatic venous outflow at any level from the small hepatic veins to the junction of the inferior vena cava with the right atrium. We present two cases of Budd–Chiari syndrome with severe ascites associated with polycythemia vera in first case and protein C deficiency in the second, in both cases transjugular intrahepatic portosystemic shunt were placed, with excellent control of symptoms, no mortality were observed, and just one episode of pulmonary venous thrombosis was observed. To our knowledge this is the first time that transjugular intrahepatic portosystemic shunt are used and reported in Budd–Chiari syndrome in Mexico.


REFERENCES

  1. Janssen HL, García-Pagan JC, Elias E, Mentha G, et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003; 38: 364-71.

  2. Senzolo M, Cholongitas EC, Patch D, Burroughs AK. Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 182-190.

  3. Okuda K, Kage M, Shrestha SM. Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology 1998; 28: 1191-1198.

  4. Hadengue A, Poliquin M, Vilgrain V, Belghiti J, Degott C, Erlinger S, et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994; 106: 1042-1047.

  5. Murad SD, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004; 39: 500-508.

  6. Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999; 30: 84-89.

  7. McCarthy PM, van Heerden JA, Adson MA, Schafer LW, Wiesner RH. The Budd-Chiari syndrome. Medical and surgical management of 30 patients. Arch Surg 1985; 120: 657-662.

  8. Mancuso A, Fung K, Mela M, Tibballs J, Watkinson A, Burroughs AK, et al. TIPS for acute and chronic Budd-Chiari syndrome: a singlecentre experience. J Hepatol 2003; 38: 751-754.

  9. Perello A, Garcia-Pagan JC, Gilabert R, Suarez Y, Moitinho E, Cervantes F, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002; 35: 132-139.

  10. Hernandez-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, et al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 2004; 40: 1197-1202.

  11. Ahn SS, Yellin A, Sheng FC, Colonna JO, Goldstein LI, Busuttil RW. Selective surgical therapy of the Budd-Chiari syndrome provides superior survivor rates than conservative medical management. J Vasc Surg 1987; 5: 28-37.

  12. Menon KV, Shah V, Kamath P. Budd-Chiari syndrome. New England Journal of Medicine 2004; 350: 578-85.

  13. Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalization and/or TIPS for Budd Chiari syndrome. Gut 2006; 55: 878-84.

  14. Molmenti EP, Segev DL, Arepally A, Hong J, Thuluvath PJ, Rai R, et al. The utility of TIPS in the management of Budd-Chiari syndrome. Ann Surg 2005; 241: 978-981.

  15. Khuroo MS, Al-Suhabani H, Al-Sebayel M, Al Ashgar H, Dahab S, Khan MQ, et al. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 2005; 20: 1494-1502.

  16. Sanyal A, Genning C, Reddy KR, Wong F, et al. The North American Study for the Treatment of Refractory Ascites. Gastroenterology 2003; 124: 634-631.

  17. Boyer T, Haskal Z. The Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension. Hepatology 2005; 41: 386-400.




2020     |     www.medigraphic.com